JP7357326B2 - プロバイオティクスを含む組成物、及びその使用方法 - Google Patents

プロバイオティクスを含む組成物、及びその使用方法 Download PDF

Info

Publication number
JP7357326B2
JP7357326B2 JP2018547873A JP2018547873A JP7357326B2 JP 7357326 B2 JP7357326 B2 JP 7357326B2 JP 2018547873 A JP2018547873 A JP 2018547873A JP 2018547873 A JP2018547873 A JP 2018547873A JP 7357326 B2 JP7357326 B2 JP 7357326B2
Authority
JP
Japan
Prior art keywords
composition
probiotic
heat
acidilactici
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018547873A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018538009A (ja
JP2018538009A5 (enExample
Inventor
リン，ジイ‐ジュ
リン，ジョリンタ
Original Assignee
イマジリン テクノロジー エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/072,308 external-priority patent/US10195237B2/en
Application filed by イマジリン テクノロジー エルエルシー filed Critical イマジリン テクノロジー エルエルシー
Publication of JP2018538009A publication Critical patent/JP2018538009A/ja
Publication of JP2018538009A5 publication Critical patent/JP2018538009A5/ja
Priority to JP2022000246A priority Critical patent/JP7385945B2/ja
Application granted granted Critical
Publication of JP7357326B2 publication Critical patent/JP7357326B2/ja
Priority to JP2023189454A priority patent/JP7699851B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
JP2018547873A 2015-11-30 2016-11-30 プロバイオティクスを含む組成物、及びその使用方法 Active JP7357326B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022000246A JP7385945B2 (ja) 2015-11-30 2022-01-04 プロバイオティクスを含む組成物、及びその使用方法
JP2023189454A JP7699851B2 (ja) 2015-11-30 2023-11-06 プロバイオティクスを含む組成物、及びその使用方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562386347P 2015-11-30 2015-11-30
US62/386,347 2015-11-30
US15/072,308 2016-03-16
US15/072,308 US10195237B2 (en) 2015-03-16 2016-03-16 Compositions and methods for treating inflammatory related diseases or conditions using Pediococcus acidilactici probiotics
PCT/US2016/064286 WO2017095968A1 (en) 2015-11-30 2016-11-30 Compositions comprising probiotics and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022000246A Division JP7385945B2 (ja) 2015-11-30 2022-01-04 プロバイオティクスを含む組成物、及びその使用方法

Publications (3)

Publication Number Publication Date
JP2018538009A JP2018538009A (ja) 2018-12-27
JP2018538009A5 JP2018538009A5 (enExample) 2020-01-16
JP7357326B2 true JP7357326B2 (ja) 2023-10-06

Family

ID=58797729

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018547873A Active JP7357326B2 (ja) 2015-11-30 2016-11-30 プロバイオティクスを含む組成物、及びその使用方法
JP2022000246A Active JP7385945B2 (ja) 2015-11-30 2022-01-04 プロバイオティクスを含む組成物、及びその使用方法
JP2023189454A Active JP7699851B2 (ja) 2015-11-30 2023-11-06 プロバイオティクスを含む組成物、及びその使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022000246A Active JP7385945B2 (ja) 2015-11-30 2022-01-04 プロバイオティクスを含む組成物、及びその使用方法
JP2023189454A Active JP7699851B2 (ja) 2015-11-30 2023-11-06 プロバイオティクスを含む組成物、及びその使用方法

Country Status (3)

Country Link
JP (3) JP7357326B2 (enExample)
CN (1) CN109803666A (enExample)
WO (1) WO2017095968A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10946050B2 (en) 2015-03-16 2021-03-16 Imagilin Technology Llc Compositions comprising probiotics and methods of use thereof
US10195237B2 (en) 2015-03-16 2019-02-05 Imagilin Technology Llc Compositions and methods for treating inflammatory related diseases or conditions using Pediococcus acidilactici probiotics
BR112017024265B1 (pt) 2015-05-11 2022-08-09 Mybiotics Pharma Ltd Métodos para crescimento de um biofilme de bactérias probióticas em partículas sólidas
CA3025210A1 (en) 2016-05-25 2017-11-30 Mybiotics Pharma Ltd. Composition and methods for microbiota therapy
CN113677212A (zh) * 2019-03-28 2021-11-19 森永乳业株式会社 耐热性细菌组合物
EP3946392A4 (en) * 2019-03-28 2022-12-07 Mybiotics Pharma Ltd Probiotic biofilm compositions and methods of preparing same
CN110079485B (zh) * 2019-05-31 2020-09-25 江南大学 缓解抑郁的乳酸片球菌ccfm6432、其发酵食品及其应用
CN111012804B (zh) * 2019-12-16 2022-05-17 南京大学 益生菌矿物材料复合制剂、矿物材料在制备抑制恶性肿瘤生长药物中的应用
KR102154255B1 (ko) * 2020-05-22 2020-09-09 (주)녹십자웰빙 유산균을 함유하는 미세먼지 자극에 의한 호흡기 질환 또는 염증 질환 치료용 조성물
CN111849805B (zh) * 2020-06-17 2022-04-22 天津科技大学 一种具有抗宫颈癌作用的乳酸片球菌及应用
KR102165930B1 (ko) * 2020-08-24 2020-10-14 (주)녹십자웰빙 유산균을 함유하는 미세먼지 자극에 의한 호흡기 질환 또는 염증 질환 치료용 조성물
KR102165929B1 (ko) * 2020-08-24 2020-10-14 (주)녹십자웰빙 유산균을 함유하는 미세먼지 자극에 의한 호흡기 질환 또는 염증 질환 치료용 조성물
CN116115582B (zh) * 2022-11-10 2024-04-16 重庆大学 前药封装的工程化益生菌及其制备方法与应用
US12491220B2 (en) 2024-02-23 2025-12-09 Imvela Corp. Compositions containing indole-derived metabolites and methods of use thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62232334A (ja) * 1986-03-31 1987-10-12 Nippon Oil & Fats Co Ltd 生きた乳酸菌入りマ−ガリン様乳化組成物の製造法
EP0574681A1 (en) * 1992-06-15 1993-12-22 Quest International B.V. Yogurt product containing bacteriocin from pediococcus adilactici
JPH08126473A (ja) * 1994-09-08 1996-05-21 Fuji Oil Co Ltd 油性組成物およびその製法並びにそれを用いた油性被覆菓子
JP2003334065A (ja) * 2002-05-16 2003-11-25 Nissei Bio Kk 乳酸菌を保護するための核酸複合体
GB0406228D0 (en) * 2004-03-19 2004-04-21 Danisco Product
JP2007529214A (ja) * 2004-03-19 2007-10-25 ダニスコ エイ／エス ショートニング用乳化剤組成物
EP1790237A1 (en) * 2005-11-02 2007-05-30 Compagnie Gervais Danone Food emulsion for use in bars, fillings, coatings and spreads and process of preparation
AP2010005111A0 (en) 2007-07-13 2010-02-28 Unilever Plc Composition comprising bacteria and lecithin
US8523837B2 (en) * 2008-10-14 2013-09-03 Mead Johnson Nutrition Company Nutritive substance delivery container
US7823723B2 (en) 2008-10-14 2010-11-02 Mead Johnson Nutrition Company Nutritive substance delivery container
US20140093614A1 (en) * 2009-09-20 2014-04-03 Mead Johnson Nutrition Company Probiotic stabilization
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
EP2420580A1 (en) 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health
US20150246082A1 (en) * 2013-01-08 2015-09-03 Imagilin Technology, Llc Pediococcus-Based Probiotics for Body Weight Control
US20140193464A1 (en) * 2013-01-08 2014-07-10 Imagilin Technology, Llc Effects of probiotics on humans and animals under environmental or biological changes
CN104472426A (zh) * 2014-11-28 2015-04-01 广西南宁劲能农业科技有限公司 一种乳香猪的饲养方法
JP6804214B2 (ja) * 2015-04-17 2020-12-23 リン， ジージューＪｈｙ−Ｊｈｕ ＬＩＮ 食品及び飼料調製のための高温耐性プロバイオティクス

Also Published As

Publication number Publication date
JP2023181539A (ja) 2023-12-21
WO2017095968A1 (en) 2017-06-08
JP7699851B2 (ja) 2025-06-30
JP7385945B2 (ja) 2023-11-24
CN109803666A (zh) 2019-05-24
JP2022033264A (ja) 2022-02-28
JP2018538009A (ja) 2018-12-27

Similar Documents

Publication Publication Date Title
JP7385945B2 (ja) プロバイオティクスを含む組成物、及びその使用方法
US11633437B2 (en) Compositions and methods for treating inflammatory related diseases or conditions using Pediococcus acidilactici probiotics
US20210252080A1 (en) Compositions comprising probiotics and methods of use thereof
RU2757213C2 (ru) Бифидобактерии для увеличения безжировой массы тела
CN109069555B (zh) 面向新生儿的用于改善脑功能的组合物
JP5925274B2 (ja) 子宮内膜症の予防及び／又は改善剤及びこれを含んでなる飲食品組成物
RU2762096C2 (ru) Бифидобактерии для снижения потребления пищи, энергии и/или жиров
JP7061560B2 (ja) スフィンゴミエリン吸収促進用兼紅斑生成抑制用発酵乳ならびにその使用方法およびその製造方法、スフィンゴミエリンの吸収を促進させると共に紅斑の生成を抑制する方法、乳酸菌産生物およびスフィンゴミエリンを含有する発酵乳
JP6037595B2 (ja) 満腹感誘導組成物及びその製造方法
CN107106618A (zh) 鞘脂吸收促进剂
WO2015087919A1 (ja) 抗菌ペプチド誘導剤
US11045508B2 (en) Composition for preventing or improving impaired renal function, pharmaceutical composition, food/beverage composition, and method of preventing or improving impaired renal function using the composition for preventing or improving impaired renal function
ES2834736T3 (es) Lactobacilli para el tratamiento de la disfunción cardíaca
JP2019081733A5 (enExample)
WO2018151245A1 (ja) インターロイキン－２３産生促進用組成物およびインターロイキン－２３の産生促進方法
JP5851242B2 (ja) チオレドキシン誘導活性を有する乳酸菌ならびにチオレドキシンを介する生体傷害の予防および／または改善用の飲食品および医薬品
WO2008026334A1 (en) Agent for inhibiting intestinal permeation of allergen
HK1262813B (en) Composition for inhibiting erythema, method of using same, method for preparing same, method for inhibiting erythema, and lactic acid bacteria product
HK1262813A1 (en) Composition for inhibiting erythema, method of using same, method for preparing same, method for inhibiting erythema, and lactic acid bacteria product

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191127

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191127

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200911

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200924

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201223

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210324

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210831

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220104

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220104

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20220118

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20220309

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20220315

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20220422

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20220426

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20230207

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20230411

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230919

R150 Certificate of patent or registration of utility model

Ref document number: 7357326

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150